Two Sigma Investments »

Atrium Therapeutics shares owned by Two Sigma Investments

Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by Two Sigma Investments from 13F filings

Historical chart of Two Sigma Investments investment in Atrium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atrium Therapeutics held by Two Sigma Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atrium Therapeutics by Two Sigma Investments

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.4M 179k 13.37

More positions owned by Two Sigma Investments

NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Palantir Technologies Cl A (PLTR)
Costco Wholesale Corporation (COST)
TJX Companies (TJX)
Mastercard Incorporated Cl A (MA)
Metropcs Communications (TMUS)
Lockheed Martin Corporation (LMT)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Micron Technology (MU)
Adobe Systems Incorporated (ADBE)

View all positions for Two Sigma Investments

Top funds holding Atrium Therapeutics

BlackRock
RA Capital Management
Vanguard Capital Management
TIG Advisors
Pentwater Capital Management
Sessa Capital IM
Goldman Sachs Group
Vanguard Portfolio Management
Geode Capital Management
683 Capital Management
Weiss Asset Management LP[1
Cantor Fitzgerald, L. P.
Balyasny Asset Management
Squarepoint Ops
Fort Hoosac Management

View all funds holding Atrium Therapeutics